Plott R T, Brysk M M, Newton R C, Raimer S S, Rajaraman S
Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock 72205.
J Dermatol Surg Oncol. 1989 Nov;15(11):1161-6. doi: 10.1111/j.1524-4725.1989.tb03229.x.
Medical treatment of vitiligo has been disappointing; therefore surgical treatments using autologous grafts have been tried. We investigated a new technique in which normally pigmented epidermal cells from a vitiligo patient were cultured on a collagen-coated membrane in MCDB-153, a media that supports melanocytes and keratinocytes. The cell/collagen-coated membrane was used to cover a superficially dermabraded vitiliginous area. Clinical repigmentation, though incomplete, was evident in three of four patients in 4 weeks. Immunofluorescence and electron microscopy were performed on the grafted areas (involved and uninvolved controls). These studies demonstrate the reappearance of melanocytes and melanosomes within the grafted area. All three patients who were successfully repigmented retained their pigment at 1 year follow-up. Further investigation of this promising treatment for vitiligo is warranted.
白癜风的药物治疗效果一直不尽人意;因此,人们尝试了使用自体移植物的手术治疗方法。我们研究了一种新技术,即从白癜风患者身上获取正常色素沉着的表皮细胞,在MCDB - 153(一种支持黑素细胞和角质形成细胞的培养基)中培养于胶原包被的膜上。将细胞/胶原包被膜用于覆盖浅表磨皮的白癜风区域。4周内,4例患者中有3例出现了临床色素再生,尽管并不完全。对移植区域(受累及未受累对照区域)进行了免疫荧光和电子显微镜检查。这些研究表明移植区域内黑素细胞和黑素小体重新出现。所有成功色素再生的3例患者在1年随访时仍保持色素沉着。有必要对这种有前景的白癜风治疗方法进行进一步研究。